Deepening row over vaccines risks bitter EU-UK fallout

EU Commission had earlier said the pharmaceutical company was refusing to attend

EU asks drugmaker if it can divert doses of vaccine from UK to make up for shortfall

Johnson & Johnson vaccine may be game-changer after clumsy missteps by AstraZeneca

Executive says company expects all deliveries to occur as agreed after it warns of delays

Dialysis patient Brian Pinker receives jab as UK rolls out Covid vaccine amid soaring cases

UK order 100 million doses of the vaccine - enough to vaccinate 50 million people

Shares down as much as 9% after weekend announcement

Almost 61 million cases confirmed worldwide as Japan, New York and Germany see rise

Drugmaker wants new test to confirm 90% efficacy rate after uncertainty and confusion

Drug maker AstraZeneca agrees to sell vaccine at cost to developing nations in perpetuity

Researchers say drug companies need to be more open with the public

Pharma industry trying to pull off unprecedented feat

Shares dip as it emerges there are no active talks on what would be politically sensitive deal

Deals involving billionaire Bill Gates guarantee early supply to lower-income countries

Drugmaker’s total revenue and earnings fell in the quarter, as analysts had expected

Results from long-awaited Mystic lung cancer study fail to show hoped-for patient recovery

Cantillon: Brexit decision may be giving Big Pharma doubts about British location

Emma Walmsley’s lack of experience cited as justification for salary

Pharmaceutical giant reports 4 per cent fall in revenue to $5.7 billion in third quarter

Drugmaker had argued against UK exit from EU over fears about drug regulation

Arrival of cheap generic rivals to cholesterol drug Crestor expected to affect revenue

Deal gives drugmaker a late-stage medicine to treat patients for a range of blood cancers

British biopharmaceutical company agrees to buy US biotech company

UK pharma group pays Actavis initial $600m for branded respiratory business in US and Canada

Company brings forward filing date for new lung cancer drug

Investors say CEO pushed too hard to make the French drugmaker more international

Pharma company’s sales in the second quarter rose 4 per cent to $6.45 billion

Grocery price war take shine off earnings

Pfizer expected to issue statement confirming offer rejection today

British pharma group may have seen off Pfizer but unsettled investors will require delivery on challenging targets it set itself in defence of the assault by US rival as share price falls

Westminster not happy with Ian Reid’s pledges on takeover of AstraZeneca

Everyone from union officials to London’s mayor has an opinion on the offer

Chief executive Pascal Soriot keen to press turnround efforts

Firm to take pretax impairment charges of $275m as part of wider restructuring programme

Drugmaker more confident following $4bn deal to buy Bristol-Myers diabetes venture

Deal involves Amylin, a US biotech they jointly purchased for $7bn last year

Ministry of industry and commerce visits office of French pharmaceutical company in Shenyang